BIAYA PENGOBATAN PASIEN KANKER PAYUDARA STADIUM AWAL YANG MENDAPATKAN KEMOTERAPI KOMBINASI 5- FLUOROURASIL, DOKSORUBISIN, SIKLOFOSFAMID (FAC) DENGAN KEMOTERAPI KOMBINASI BERBASIS TAXAN

Background: Cancer is an important problem in health and economics. It caused by high morbidity and mortality rate, bad prognosys and chemotherapy resistance which cause the number of cancer patient increase annually. Appropriate selection of combination chemotherapy has an important role to outcome...

ver descrição completa

Detalhes bibliográficos
Principais autores: , Didik Setiawan S. Farm, , Prof. dr. Iwan Dwiprahasto, M.Med.Sc., Ph.D.
Formato: Tese
Publicado em: [Yogyakarta] : Universitas Gadjah Mada 2011
Assuntos:
ETD